This positive regulatory role suggests that USP38 may serve as a potential tumor biomarker involved in regulating tumor cell growth (85).However, current research on the USP38/Survivin signaling axis is limited to breast cancer and hepatocellular carcinoma. This evidence concerns the gene USP38 and hepatocellular carcinoma.